期刊文献+

围绝经期妇女激素替代治疗的临床效果观察 被引量:8

The Clinical Effect of Hormone Replacement Therapy in Perimenopausal Women
下载PDF
导出
摘要 目的探讨围绝经期妇女激素替代治疗的临床疗效。方法 100例围绝经期综合征妇女随机分为观察组和对照组,对照组采用常规治疗,观察组采用激素替代疗法。比较两组治疗前后激素水平变化以及临床疗效。结果观察组治疗后的FSH、LH低于对照组,E2高于对照组,有统计学意义(P<0.05)。观察组总有效率为98.0%,高于对照组的72.0%,差异有统计学意义(P<0.05)。两组均未见明显不良反应。结论激素替代疗法能够改善围绝经期综合征妇女的激素水平,缓解患者的临床症状。 Objective To investigate the clinical effect of hormone replacement therapy in perimenopausal women. Methods 100 cases of perimenopausal syndrome patients were randomly divided into the observation group and the control group, the control group was used the conventional treatment, the observation group was given hormone replacement therapy. The two groups were compared with the changes of hormone levels and the clinical curative effect. Results FSH, LH after treatment in the observation group was lower than that in the control group, E2 was higher than that in the control group, there was statistical significance(P〈0.05). Total efficiency in the observation group was 98% higher than 72.0% in the control group, there was statistical significance(P〈0.05). Two groups were no obvious adverse reactions. Conclusion Hormone replacement therapy can improve perimenopausal syndrome women's hormone levels; relieve the clinical symptoms.
作者 刘艳
出处 《中国继续医学教育》 2015年第15期149-150,共2页 China Continuing Medical Education
关键词 围绝经期 激素替代疗法 激素水平 疗效 Menopause Hormone replacement therapy Hormone Curative effect
  • 相关文献

参考文献6

二级参考文献29

  • 1杨清,王玉.女性围绝经期综合征的激素替代治疗[J].实用药物与临床,2005,8(3):6-8. 被引量:7
  • 2李慧林,朱汉民,程群,陈小平,朱晓颖,张雪梅.绝经妇女绝经后年限及年龄与骨量丢失率关系[J].中国骨质疏松杂志,2007,13(7):502-504. 被引量:25
  • 3Smolinski D, Wollner D, Orlowski J, et al. A pilot study to examine a combination botanical for the treatment of menopausal symptoms [J]. J Altern Complement Med, 2005,11 (3) : 483 - 489.
  • 4曹泽毅.中华妇产科学(下册)[M].2版.北京:人民卫生出版社,2005:2537.
  • 5Parker WH, Broder MS, Liu Z, et al. Ovarian conservation at the time of hysterectomy for benign disease [J]. Clin Obstet Gynecol, 2007,50(2): 354 - 361.
  • 6Ldx~ RA. Surgical menopause and cardiovascular risks [J]. Menopause, 2007,14(3) :562 - 566.
  • 7Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women [J]. J Clin Endocrinol Metab,2008,93(3) :861 - 868.
  • 8Wakatsuki A, Ikenoue N, Shinohaza K, et al. Effect of lower dos- age of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women [ J ]. Arterioseler Thromb Vase BioL 2004,24(3 ) :571 - 576.
  • 9Ross R, Glomset JA. Atheroselerosis and the arterial smooth muscle cell: Proliferation of smooth musclel5 a key event in the genesis of the lesions of atheroselerosis [J]. Science,1973,180 (4093) : 1332 - 1339.
  • 10黄灵霞.围绝经期综合征与HRT的临床应用[C].中华医学会第三次全国绝经学术会议暨绝经相关问题学习班论文汇编,2011.

共引文献94

同被引文献76

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部